Peritoneal effects of intravenous iron sucrose administration in rats

Andrzej Breborowicz, Alicja Polubinska, Maciej Breborowicz, Marek Simon, Maria Wanic-Kossowska, Dimitrios G. Oreopoulos

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Intravenous iron supplementation is commonly used in uremic patients treated with peritoneal dialysis. Infusion of iron compounds results in various systemic noxious effects, mainly because of its prooxidant and proinflammatory actions. The authors studied how the intravenous infusion of iron sucrose (IS) affects intraperitoneal homeostasis in rats undergoing acute peritoneal dialysis. Experiments were performed on Wistar rats, which were infused intravenously with IS in a dose 10 mg/kg body weight or with normal saline in the controls. Simultaneously, 4-hour acute peritoneal dialysis was started. At the end of the dialysis, systemic and peritoneal inflammatory reaction and peritoneal permeability were evaluated. Compared with controls, rats exposed to IS showed increased dialysate iron concentration by +70%, P < 0.001, and in the differential cell count, more eosinophils (+113%, P < 0.05) and fewer macrophages (-16%, P < 0.05) existed. In in vitro conditions, macrophages obtained from IS-treated rats released more tumor necrosis factor-alpha (TNF-α; +173%, P < 0.05) upon stimulation with endotoxin. Additionally increased (+73%, P < 0.01) dialysate elastase activity was found in IS-treated animals. Rats infused with IS demonstrated increased peritoneal permeability to total protein (+60%, P < 0.001) as compared with control animals. When rats with simultaneous peritonitis received intravenous IS, ex vivo isolated peritoneal leukocytes generated more free radicals (+73%, P < 0.05) than did cells harvested from control animals. It has been concluded that intravenous infusion of IS affects the intraperitoneal homeostasis in rats, moving it toward the inflammatory state. These changes may contribute to peritoneal damage.

Original languageEnglish (US)
Pages (from-to)304-309
Number of pages6
JournalTranslational Research
Volume149
Issue number6
DOIs
StatePublished - Jun 2007
Externally publishedYes

Fingerprint

saccharated ferric oxide
Rats
Dialysis
Peritoneal Dialysis
Animals
Macrophages
Dialysis Solutions
Intravenous Infusions
Permeability
Homeostasis
Iron
Rat control
Iron Compounds
Pancreatic Elastase
Peritonitis
Eosinophils

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, medical
  • Public Health, Environmental and Occupational Health

Cite this

Breborowicz, A., Polubinska, A., Breborowicz, M., Simon, M., Wanic-Kossowska, M., & Oreopoulos, D. G. (2007). Peritoneal effects of intravenous iron sucrose administration in rats. Translational Research, 149(6), 304-309. https://doi.org/10.1016/j.trsl.2006.11.003

Peritoneal effects of intravenous iron sucrose administration in rats. / Breborowicz, Andrzej; Polubinska, Alicja; Breborowicz, Maciej; Simon, Marek; Wanic-Kossowska, Maria; Oreopoulos, Dimitrios G.

In: Translational Research, Vol. 149, No. 6, 06.2007, p. 304-309.

Research output: Contribution to journalArticle

Breborowicz, A, Polubinska, A, Breborowicz, M, Simon, M, Wanic-Kossowska, M & Oreopoulos, DG 2007, 'Peritoneal effects of intravenous iron sucrose administration in rats', Translational Research, vol. 149, no. 6, pp. 304-309. https://doi.org/10.1016/j.trsl.2006.11.003
Breborowicz A, Polubinska A, Breborowicz M, Simon M, Wanic-Kossowska M, Oreopoulos DG. Peritoneal effects of intravenous iron sucrose administration in rats. Translational Research. 2007 Jun;149(6):304-309. https://doi.org/10.1016/j.trsl.2006.11.003
Breborowicz, Andrzej ; Polubinska, Alicja ; Breborowicz, Maciej ; Simon, Marek ; Wanic-Kossowska, Maria ; Oreopoulos, Dimitrios G. / Peritoneal effects of intravenous iron sucrose administration in rats. In: Translational Research. 2007 ; Vol. 149, No. 6. pp. 304-309.
@article{d334e4f555d34fee887ec2b3544d0c58,
title = "Peritoneal effects of intravenous iron sucrose administration in rats",
abstract = "Intravenous iron supplementation is commonly used in uremic patients treated with peritoneal dialysis. Infusion of iron compounds results in various systemic noxious effects, mainly because of its prooxidant and proinflammatory actions. The authors studied how the intravenous infusion of iron sucrose (IS) affects intraperitoneal homeostasis in rats undergoing acute peritoneal dialysis. Experiments were performed on Wistar rats, which were infused intravenously with IS in a dose 10 mg/kg body weight or with normal saline in the controls. Simultaneously, 4-hour acute peritoneal dialysis was started. At the end of the dialysis, systemic and peritoneal inflammatory reaction and peritoneal permeability were evaluated. Compared with controls, rats exposed to IS showed increased dialysate iron concentration by +70{\%}, P < 0.001, and in the differential cell count, more eosinophils (+113{\%}, P < 0.05) and fewer macrophages (-16{\%}, P < 0.05) existed. In in vitro conditions, macrophages obtained from IS-treated rats released more tumor necrosis factor-alpha (TNF-α; +173{\%}, P < 0.05) upon stimulation with endotoxin. Additionally increased (+73{\%}, P < 0.01) dialysate elastase activity was found in IS-treated animals. Rats infused with IS demonstrated increased peritoneal permeability to total protein (+60{\%}, P < 0.001) as compared with control animals. When rats with simultaneous peritonitis received intravenous IS, ex vivo isolated peritoneal leukocytes generated more free radicals (+73{\%}, P < 0.05) than did cells harvested from control animals. It has been concluded that intravenous infusion of IS affects the intraperitoneal homeostasis in rats, moving it toward the inflammatory state. These changes may contribute to peritoneal damage.",
author = "Andrzej Breborowicz and Alicja Polubinska and Maciej Breborowicz and Marek Simon and Maria Wanic-Kossowska and Oreopoulos, {Dimitrios G.}",
year = "2007",
month = "6",
doi = "10.1016/j.trsl.2006.11.003",
language = "English (US)",
volume = "149",
pages = "304--309",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "6",

}

TY - JOUR

T1 - Peritoneal effects of intravenous iron sucrose administration in rats

AU - Breborowicz, Andrzej

AU - Polubinska, Alicja

AU - Breborowicz, Maciej

AU - Simon, Marek

AU - Wanic-Kossowska, Maria

AU - Oreopoulos, Dimitrios G.

PY - 2007/6

Y1 - 2007/6

N2 - Intravenous iron supplementation is commonly used in uremic patients treated with peritoneal dialysis. Infusion of iron compounds results in various systemic noxious effects, mainly because of its prooxidant and proinflammatory actions. The authors studied how the intravenous infusion of iron sucrose (IS) affects intraperitoneal homeostasis in rats undergoing acute peritoneal dialysis. Experiments were performed on Wistar rats, which were infused intravenously with IS in a dose 10 mg/kg body weight or with normal saline in the controls. Simultaneously, 4-hour acute peritoneal dialysis was started. At the end of the dialysis, systemic and peritoneal inflammatory reaction and peritoneal permeability were evaluated. Compared with controls, rats exposed to IS showed increased dialysate iron concentration by +70%, P < 0.001, and in the differential cell count, more eosinophils (+113%, P < 0.05) and fewer macrophages (-16%, P < 0.05) existed. In in vitro conditions, macrophages obtained from IS-treated rats released more tumor necrosis factor-alpha (TNF-α; +173%, P < 0.05) upon stimulation with endotoxin. Additionally increased (+73%, P < 0.01) dialysate elastase activity was found in IS-treated animals. Rats infused with IS demonstrated increased peritoneal permeability to total protein (+60%, P < 0.001) as compared with control animals. When rats with simultaneous peritonitis received intravenous IS, ex vivo isolated peritoneal leukocytes generated more free radicals (+73%, P < 0.05) than did cells harvested from control animals. It has been concluded that intravenous infusion of IS affects the intraperitoneal homeostasis in rats, moving it toward the inflammatory state. These changes may contribute to peritoneal damage.

AB - Intravenous iron supplementation is commonly used in uremic patients treated with peritoneal dialysis. Infusion of iron compounds results in various systemic noxious effects, mainly because of its prooxidant and proinflammatory actions. The authors studied how the intravenous infusion of iron sucrose (IS) affects intraperitoneal homeostasis in rats undergoing acute peritoneal dialysis. Experiments were performed on Wistar rats, which were infused intravenously with IS in a dose 10 mg/kg body weight or with normal saline in the controls. Simultaneously, 4-hour acute peritoneal dialysis was started. At the end of the dialysis, systemic and peritoneal inflammatory reaction and peritoneal permeability were evaluated. Compared with controls, rats exposed to IS showed increased dialysate iron concentration by +70%, P < 0.001, and in the differential cell count, more eosinophils (+113%, P < 0.05) and fewer macrophages (-16%, P < 0.05) existed. In in vitro conditions, macrophages obtained from IS-treated rats released more tumor necrosis factor-alpha (TNF-α; +173%, P < 0.05) upon stimulation with endotoxin. Additionally increased (+73%, P < 0.01) dialysate elastase activity was found in IS-treated animals. Rats infused with IS demonstrated increased peritoneal permeability to total protein (+60%, P < 0.001) as compared with control animals. When rats with simultaneous peritonitis received intravenous IS, ex vivo isolated peritoneal leukocytes generated more free radicals (+73%, P < 0.05) than did cells harvested from control animals. It has been concluded that intravenous infusion of IS affects the intraperitoneal homeostasis in rats, moving it toward the inflammatory state. These changes may contribute to peritoneal damage.

UR - http://www.scopus.com/inward/record.url?scp=34249315417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249315417&partnerID=8YFLogxK

U2 - 10.1016/j.trsl.2006.11.003

DO - 10.1016/j.trsl.2006.11.003

M3 - Article

VL - 149

SP - 304

EP - 309

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 6

ER -